002773.SZ Stock Analysis
00
Attractive
Based on Eyestock quantitative analysis, 002773.SZ`s fundamental data and valuation indicate an investment grade of Attractive at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, manufacture and distribution of biological products, traditional Chinese medicines, and chemical drugs. The company is headquartered in Chengdu, Sichuan and currently employs 3,848 full-time employees. The company went IPO on 2015-06-26. The Company’s main products include Conbercept Ophthalmic Injection, Songling capsules conducive to blood vessels, Keluoxin capsules, venlafaxine hydrochloride capsules and sustained release tablets, aripiprazole tablets and orally disintegrating tablets, mosapride citrate tablets and dispersible tablets, dexzopiclone tablets, Shuganjieyu capsules, Danshu capsules and Yiqing capsules, among others. The firm distributes its products in domestic market.